These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. [Intensive chemotherapy for alveolar soft part sarcoma with lung metastasis in a child]. Hibi S; Naya M; Takaya K; Morimoto M; Kataoka Y; Todo S; Imashuku S Gan To Kagaku Ryoho; 1993 Jul; 20(9):1249-52. PubMed ID: 8333754 [TBL] [Abstract][Full Text] [Related]
44. Efficacy of sequential high-dose doxorubicin and ifosfamide compared with standard-dose doxorubicin in patients with advanced soft tissue sarcoma: an open-label randomized phase II study of the Spanish group for research on sarcomas. Maurel J; López-Pousa A; de Las Peñas R; Fra J; Martín J; Cruz J; Casado A; Poveda A; Martínez-Trufero J; Balañá C; Gómez MA; Cubedo R; Gallego O; Rubio-Viqueira B; Rubió J; Andrés R; Sevilla I; de la Cruz JJ; Del Muro XG; Buesa JM J Clin Oncol; 2009 Apr; 27(11):1893-8. PubMed ID: 19273704 [TBL] [Abstract][Full Text] [Related]
45. [A difficult case of advanced testicular choriocarcinoma effectively treated by chemotherapy and resection of lung metastasis]. Ishizuka O; Satoh T; Mizuno H; Mizusawa H; Seki S; Nishizawa O Gan To Kagaku Ryoho; 2004 Feb; 31(2):263-5. PubMed ID: 14997765 [TBL] [Abstract][Full Text] [Related]
46. Ifosfamide in soft tissue sarcoma. Zaidi SH; Iqbal Z; Mallick JA J Pak Med Assoc; 1990 Sep; 40(9):222-4. PubMed ID: 2123272 [No Abstract] [Full Text] [Related]
47. Surgical adjuvant therapy for soft tissue sarcomas. Townsend CM Surg Clin North Am; 1981 Dec; 61(6):1405-13. PubMed ID: 7031939 [No Abstract] [Full Text] [Related]
48. Optimizing clinical care in patients with advanced soft tissue sarcoma: a phase II study of a new schedule of high-dose continuous infusion ifosfamide and doxorubicin combination. De Pas T; Rosati G; Spitaleri G; Boni C; Tucci A; Frustaci S; Scalamogna R; Radice D; Boselli S; Toffalorio F; Catania C; Noberasco C; Delmonte A; Vecchio F; de Braud F Chemotherapy; 2011; 57(3):217-24. PubMed ID: 21597285 [TBL] [Abstract][Full Text] [Related]
49. Ifosfamide in the treatment of extensive non-oat cell carcinoma of the lung. Costanzi JJ; Morgan LR; Hokanson J Semin Oncol; 1982 Dec; 9(4 Suppl 1):61-5. PubMed ID: 6298945 [No Abstract] [Full Text] [Related]
50. Ifosfamide and Mesna in advanced malignancies. Li GC; Brock N; Li JQ; Guan ZZ; He YJ Chin Med J (Engl); 1988 Mar; 101(3):213-20. PubMed ID: 3136996 [No Abstract] [Full Text] [Related]
51. Cyclophosphamide versus ifosfamide: a randomized phase II trial in adult soft-tissue sarcomas. The European Organization for Research and Treatment of Cancer [EORTC], Soft Tissue and Bone Sarcoma Group. Bramwell VH; Mouridsen HT; Santoro A; Blackledge G; Somers R; Verweij J; Dombernowsky P; Onsrud M; Thomas D; Sylvester R Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S180-4. PubMed ID: 8453694 [TBL] [Abstract][Full Text] [Related]
53. The role of ifosfamide in the treatment of sarcomas. Dirix LY; Van Oosterom AT Semin Oncol; 1989 Feb; 16(1 Suppl 3):39-45. PubMed ID: 2649984 [TBL] [Abstract][Full Text] [Related]
54. The value of ifosfamide in the polychemotherapy of metastasized testicular cancer pretreated with chemotherapy. Clemm C; Hartenstein R; Wilmanns W Arzneimittelforschung; 1982; 32(12):1557-60. PubMed ID: 6891596 [TBL] [Abstract][Full Text] [Related]
55. Testicular function of survivors of childhood cancer: a comparative study between ifosfamide- and cyclophosphamide-based regimens. Ridola V; Fawaz O; Aubier F; Bergeron C; de Vathaire F; Pichon F; Orbach D; Gentet JC; Schmitt C; Dufour C; Oberlin O Eur J Cancer; 2009 Mar; 45(5):814-8. PubMed ID: 19216070 [TBL] [Abstract][Full Text] [Related]
56. Controlled studies with bleomycin in solid tumors and lymphomas. Bonadonna G; Tancini G; Bajetta E Prog Biochem Pharmacol; 1976; 11():172-84. PubMed ID: 63961 [No Abstract] [Full Text] [Related]
57. [Modern chemotherapy of a malignant testicular tumors (author's transl)]. Arnold H; Fiebig HH Radiologe; 1981 Sep; 21(9):421-30. PubMed ID: 6170087 [TBL] [Abstract][Full Text] [Related]
58. Toxicity of single- vs. fractionated-dose ifosfamide in non-small cell lung cancer: a multi-center study. Morgan LR; Harrison EF; Hawke JE; Hunter HL; Costanzi JJ; Plotkin D; Tucker WG; Worrall PM Semin Oncol; 1982 Dec; 9(4 Suppl 1):66-70. PubMed ID: 7163813 [No Abstract] [Full Text] [Related]
59. Phase I study of high-dose ifosfamide, carboplatin and etoposide with autologous hematopoietic stem cell support. Elias AD; Ayash LJ; Wheeler C; Schwartz G; Tepler I; Gonin R; McCauley M; Mazanet R; Schnipper L; Frei E Bone Marrow Transplant; 1995 Mar; 15(3):373-9. PubMed ID: 7599561 [TBL] [Abstract][Full Text] [Related]
60. Prognostic and predictive factors for outcome to first-line ifosfamide-containing chemotherapy for adult patients with advanced soft tissue sarcomas: an exploratory, retrospective analysis on large series from the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG). Sleijfer S; Ouali M; van Glabbeke M; Krarup-Hansen A; Rodenhuis S; Le Cesne A; Hogendoorn PC; Verweij J; Blay JY Eur J Cancer; 2010 Jan; 46(1):72-83. PubMed ID: 19853437 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]